Retatrutide is a triple agonist, meaning it targets three hormone receptor agonists: GLP-1, GIP and glucagon (GCG). It’s ...

Some of the platforms in the ranking below may offer medications (like Ozempic) that are not approved by the U.S. Food and ...

Weight-loss drugs built around the hormone GLP-1 have changed what obesity treatment can look like, but the headline numbers only tell part of the story. In a large real-world analysis, some patients ...

Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...

The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.

FDA accepts two applications for generic weight loss drugs amid international competition as well as issues of patents and ...

Tirzepatide reduced sleep apnea events and improved weight loss, reshaping treatment for nighttime breathing disorders.

Zealthy today announced the launch of a dedicated tirzepatide care pathway within its virtual weight-management platform. GLP-1s from Zealthy The new workflow is designed to centralize the steps ...

TORONTO, Nov. 2, 2023 /CNW/ - Lilly Canada is pleased to announce that Mounjaro ® (tirzepatide) is now available in Canada. Mounjaro is a new once-weekly GIP (glucose-dependent insulinotropic ...

SAHPRA has recalled compounded Semaglutide and Tirzepatide products over serious safety concerns and urges patients to stop ...